Global Vertebroplasty and Kyphoplasty Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Vertebroplasty and Kyphoplasty Market Overview

The Vertebroplasty and Kyphoplasty Market was valued at USD 970.98 Million in 2025 and is projected to reach USD 1412.86 Million by 2033, growing at a CAGR of 4.80% from 2026 to 2033. The Vertebroplasty and Kyphoplasty market is experiencing steady growth driven by rising prevalence of osteoporosis-related vertebral compression fractures, increasing aging population worldwide, and growing demand for minimally invasive spinal procedures. Advancements in image-guided surgical systems, biomaterials such as polymethylmethacrylate (PMMA) bone cement, and improved balloon catheter technologies are further enhancing procedural safety, accuracy, and patient recovery outcomes.

The increasing incidence of spinal fractures due to osteoporosis, trauma, and metastatic bone disease is driving higher adoption of vertebroplasty and kyphoplasty procedures across hospitals and ambulatory surgical centers. Rising awareness among patients and physicians regarding minimally invasive alternatives to open spine surgery is further accelerating demand. In addition, expanding access to advanced interventional radiology suites, improved reimbursement policies in developed regions, and increasing adoption of outpatient spine procedures are supporting market growth globally.

Key Market Trends & Insights

• North America dominated the Vertebroplasty and Kyphoplasty Market with the largest revenue share of 38.92% in 2025, supported by advanced healthcare infrastructure, high adoption of minimally invasive spinal procedures, strong presence of skilled orthopedic surgeons and interventional radiologists, and well-established reimbursement systems. The region also benefits from a high burden of osteoporosis-related vertebral compression fractures among the aging population, along with strong adoption of image-guided surgical technologies and advanced biomaterials used in spinal augmentation procedures.
• The Vertebroplasty segment dominated the market with a share of 56.3% in 2025, owing to its wide clinical adoption for treating osteoporotic vertebral compression fractures and its relatively lower procedural cost compared to Kyphoplasty.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.2% from 2026 to 2033, fueled by rising geriatric population, increasing incidence of osteoporosis and trauma-related spinal fractures, expanding healthcare infrastructure, and improving access to minimally invasive spine procedures across countries such as China, India, and Japan. Growing medical tourism and increasing healthcare spending are also supporting regional expansion.
• The Vertebroplasty segment is expected to grow steadily during the forecast period, supported by its cost-effectiveness, shorter procedure duration, and widespread use in pain management for vertebral compression fractures, particularly in resource-constrained and outpatient care settings.
• The Hospitals segment dominated the end-use category in 2025, driven by availability of advanced imaging systems, skilled surgical expertise, and comprehensive post-operative care facilities required for vertebral augmentation procedures. High patient inflow for osteoporosis, trauma, and cancer-related spinal fractures further reinforces hospital dominance in the market.
• The Ambulatory Surgery Centres (ASCs) segment is expected to witness the fastest CAGR of 6–7% from 2026 to 2033, supported by the growing shift toward minimally invasive outpatient procedures, lower treatment costs, faster recovery times, and increasing preference for same-day discharge spine interventions in developed healthcare systems.

Market Size & Forecast

• Global Market Value (2025): USD 970.98 Million
• Expected Market Value (2033): USD 1412.86 Million
• Forecast CAGR (2026–2033): 4.80%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia-Pacific

Report Scope and Vertebroplasty and Kyphoplasty Market Segmentation

Vertebroplasty and Kyphoplasty Market Trends

Trend: Rising Adoption of Minimally Invasive Spine Augmentation Procedures

The Vertebroplasty and Kyphoplasty Market is witnessing strong growth driven by increasing preference for minimally invasive spine procedures in treating vertebral compression fractures. These procedures are widely used in osteoporosis-related spinal injuries, which are rising globally due to aging populations. According to clinical studies, osteoporotic fractures affect approximately 200 million women worldwide, significantly increasing demand for cement-based vertebral stabilization procedures. Kyphoplasty adoption is increasing due to its ability to restore vertebral height and reduce kyphotic deformity compared to vertebroplasty. In addition, advancements in image-guided fluoroscopy and balloon-assisted systems are improving procedural accuracy, reducing complication rates, and enhancing recovery outcomes, leading to higher adoption in hospitals and specialty spine centers.

Vertebroplasty and Kyphoplasty Market Dynamics

Key Market Driver: Rising Prevalence of Osteoporosis and Age-Related Spinal Fractures

The increasing global burden of osteoporosis and degenerative spine conditions is a major driver of the vertebroplasty and kyphoplasty market. According to the International Osteoporosis Foundation (IOF), more than 8.9 million osteoporotic fractures occur annually worldwide, with vertebral compression fractures being one of the most common. The growing elderly population—projected to reach 1.4 Million people aged 60+ by 2030 (UN data)—is significantly expanding the patient pool requiring spinal stabilization procedures. Increasing awareness of early treatment options, improved reimbursement policies in developed regions, and rising access to minimally invasive surgical techniques are further accelerating market growth globally.

Key Restraint/Challenge: Procedure-Related Risks and High Treatment Costs

A major challenge in the vertebroplasty and kyphoplasty market is the risk of procedural complications and high treatment costs, which can limit adoption in cost-sensitive healthcare systems. Complications such as cement leakage, adjacent vertebral fractures, and infection risk, although relatively low, remain clinically significant concerns. In addition, the cost of kyphoplasty procedures is higher than vertebroplasty due to balloon systems and specialized equipment, limiting uptake in developing regions. Limited access to trained spine surgeons and advanced imaging infrastructure in rural healthcare settings further restricts market penetration. Additionally, reimbursement limitations in some countries create financial barriers for widespread adoption.

Key Market Opportunity: Technological Advancements in Image-Guided and Robotic Spine Surgery The integration of advanced imaging technologies, navigation systems, and robotic-assisted spine surgery presents a major growth opportunity for the vertebroplasty and kyphoplasty market. Technologies such as 3D imaging, intraoperative CT navigation, and AI-assisted surgical planning are improving procedural precision and safety. Leading medical device companies like Medtronic and Stryker are investing in next-generation vertebral augmentation systems with enhanced cement delivery control and reduced leakage risk. Furthermore, increasing adoption of outpatient and ambulatory spine surgery centers is expanding access to minimally invasive procedures. Emerging markets in Asia-Pacific and Latin America are also witnessing rapid growth due to expanding healthcare infrastructure and rising awareness of osteoporosis treatment options.

Vertebroplasty and Kyphoplasty Market Scope

The Vertebroplasty and Kyphoplasty market is segmented on the basis of product and end-use.

• By Product

On the basis of product, the Vertebroplasty and Kyphoplasty Market is segmented into Vertebroplasty and Kyphoplasty. The Vertebroplasty segment dominated the market with a share of 56.3% in 2025, owing to its wide clinical adoption for treating osteoporotic vertebral compression fractures and its relatively lower procedural cost compared to Kyphoplasty. Vertebroplasty is widely preferred in developing and cost-sensitive healthcare systems due to shorter procedure time and established reimbursement coverage in several regions. Increasing prevalence of osteoporosis, particularly among the elderly population, is further driving demand for cement-based vertebral stabilization procedures. Hospitals and spine care centers continue to adopt Vertebroplasty as a first-line minimally invasive treatment in suitable cases. Strong clinical familiarity and availability of trained specialists further reinforce segment dominance globally. However, rising awareness of advanced spinal correction techniques is gradually influencing treatment preferences.

The Kyphoplasty segment is expected to register the faster CAGR of 6.8% from 2026 to 2033, driven by its superior clinical benefits such as vertebral height restoration and reduced risk of cement leakage compared to Vertebroplasty. Kyphoplasty is increasingly preferred for patients with severe spinal deformity and acute vertebral compression fractures. Growing adoption in developed healthcare markets is supported by better patient outcomes and reduced post-operative complications. Technological advancements in balloon-assisted systems and image-guided surgery are improving procedural accuracy and safety. Rising demand for minimally invasive spine surgeries among aging populations is further supporting growth. Expanding hospital infrastructure and increasing physician awareness are accelerating Kyphoplasty adoption globally.

• By End-Use

On the basis of end-use, the Vertebroplasty and Kyphoplasty Market is segmented into Hospitals and Ambulatory Surgery Centres (ASCs). The Hospitals segment dominated the market with a share of 71.2% in 2025, due to the availability of advanced surgical infrastructure, skilled spine surgeons, and high patient inflow for complex vertebral fracture cases. Hospitals are the primary centers for minimally invasive spine procedures as they provide integrated diagnostic, surgical, and post-operative care facilities. Strong reimbursement frameworks in developed economies further support hospital-based procedures. Increasing incidence of osteoporosis-related fractures is also contributing to higher hospitalization rates. Hospitals also benefit from better access to imaging systems such as fluoroscopy and CT guidance, which are essential for these procedures. The presence of multidisciplinary spine care teams strengthens hospital dominance in this market.

The Ambulatory Surgery Centres (ASCs) segment is expected to register the faster CAGR of 7.1% from 2026 to 2033, driven by the increasing shift toward outpatient and cost-effective surgical procedures. ASCs offer reduced hospital stay, lower procedural costs, and faster patient recovery, making them highly attractive for elderly patients. Rising healthcare cost pressures are pushing providers to adopt minimally invasive outpatient care models. Advances in surgical techniques have made vertebroplasty and kyphoplasty safer for same-day procedures. Increasing investments in ambulatory surgical infrastructure, especially in North America and Europe, are further supporting growth. Expanding insurance coverage for outpatient spine procedures is also accelerating adoption globally.

Vertebroplasty and Kyphoplasty Market Regional Analysis

North America dominated the Vertebroplasty and Kyphoplasty Market and accounted for the largest revenue share of 38.92% in 2025, supported by advanced healthcare infrastructure, high adoption of minimally invasive spinal procedures, and strong presence of skilled orthopedic surgeons and interventional radiologists. The region benefits from a high prevalence of osteoporosis-related vertebral compression fractures, particularly among the rapidly aging population. Increasing use of image-guided surgical systems, advanced bone cement technologies, and balloon kyphoplasty devices is further strengthening market growth. Well-established reimbursement frameworks and strong adoption of outpatient spine procedures also contribute to regional dominance. In addition, continuous technological advancements in spinal augmentation techniques are improving clinical outcomes and accelerating procedure adoption across hospitals and specialty clinics.

U.S. Vertebroplasty and Kyphoplasty Market Insight

The U.S. Vertebroplasty and Kyphoplasty market is witnessing steady growth due to a high burden of osteoporosis and spinal fractures, along with strong availability of advanced healthcare facilities. The country has a well-developed spine care ecosystem, including specialized hospitals and ambulatory surgical centers performing minimally invasive vertebral augmentation procedures. Increasing adoption of kyphoplasty for vertebral height restoration and pain management is driving demand. In addition, favorable reimbursement policies and widespread use of fluoroscopy and CT-guided procedures are supporting market expansion. Rising geriatric population and increasing awareness of early fracture treatment are further strengthening growth in the United States.

Europe Vertebroplasty and Kyphoplasty Market Insight

The Europe Vertebroplasty and Kyphoplasty market remains a major contributor to global revenue, driven by strong healthcare systems, high prevalence of osteoporosis, and increasing adoption of minimally invasive spine surgeries. Countries such as Germany, France, and Italy are witnessing rising procedure volumes supported by advanced hospital infrastructure and skilled specialists. The region benefits from strong regulatory support for medical devices and increasing use of advanced imaging-guided systems. Growing elderly population and rising incidence of vertebral compression fractures are further boosting demand. Additionally, increasing preference for outpatient spine procedures is supporting market expansion across Europe.

U.K. Vertebroplasty and Kyphoplasty Market Insight

The U.K. Vertebroplasty and Kyphoplasty market is experiencing steady growth due to increasing prevalence of osteoporosis and rising demand for minimally invasive spinal treatments. The National Health Service (NHS) plays a key role in providing access to vertebral augmentation procedures, particularly for elderly patients. Growing adoption of kyphoplasty due to better clinical outcomes and reduced complication risks is supporting market growth. In addition, advancements in image-guided surgical techniques and increasing availability of specialized spine care centers are further strengthening the market in the United Kingdom.

Germany Vertebroplasty and Kyphoplasty Market Insight

The Germany Vertebroplasty and Kyphoplasty market is expanding steadily due to strong orthopedic healthcare infrastructure, high adoption of advanced medical technologies, and a large aging population. Germany is one of the leading markets in Europe for minimally invasive spine procedures, supported by advanced imaging systems and skilled interventional radiologists. Increasing use of kyphoplasty for vertebral height restoration and pain reduction is driving procedural growth. In addition, strong healthcare funding and continuous innovation in spinal biomaterials are further supporting market expansion.

Asia-Pacific Vertebroplasty and Kyphoplasty Market Insight

The Asia-Pacific Vertebroplasty and Kyphoplasty market is expected to witness rapid growth, driven by rising geriatric population, increasing incidence of osteoporosis, and expanding healthcare infrastructure. Countries such as China, India, and Japan are experiencing growing demand for minimally invasive spine procedures due to improving access to advanced healthcare services. Increasing healthcare expenditure, rising awareness of spinal fracture treatments, and growing adoption of modern surgical technologies are further supporting regional expansion. In addition, medical tourism and expanding hospital networks are accelerating market growth across Asia-Pacific.

Japan Vertebroplasty and Kyphoplasty Market Insight

The Japan Vertebroplasty and Kyphoplasty market is witnessing steady growth due to a rapidly aging population and high prevalence of osteoporosis-related fractures. Japan has one of the highest proportions of elderly individuals globally, significantly increasing demand for spinal augmentation procedures. Advanced healthcare infrastructure and strong adoption of minimally invasive surgical technologies are supporting market expansion. In addition, increasing use of kyphoplasty for improved spinal correction outcomes is further driving procedure adoption in the country.

China Vertebroplasty and Kyphoplasty Market Insight

The China Vertebroplasty and Kyphoplasty market is growing rapidly due to rising aging population, increasing incidence of osteoporosis, and expanding healthcare infrastructure. Government investments in healthcare modernization and increasing access to advanced surgical procedures are significantly supporting market growth. Growing adoption of minimally invasive spine surgeries in urban hospitals and increasing availability of skilled surgeons are further accelerating demand. In addition, rising healthcare expenditure and expanding hospital networks are positioning China as one of the fastest-growing markets globally for vertebral augmentation procedures.

Vertebroplasty and Kyphoplasty Market Share

The Vertebroplasty and Kyphoplasty industry is primarily led by well-established companies, including:

• Medtronic plc (Ireland/U.S.)
• Stryker Corporation (U.S.)
• Johnson & Johnson (DePuy Synthes) (U.S.)
• Globus Medical Inc. (U.S.)
• Zimmer Biomet Holdings Inc. (U.S.)
• Alphatec Holdings Inc. (U.S.)
• Orthofix Medical Inc. (U.S.)
• Teknimed S.A. (France)
• Cook Medical LLC (U.S.)
• Merit Medical Systems Inc. (U.S.)
• Vexim (a Stryker company) (France)
• DFINE Inc. (U.S.)
• Joimax GmbH (Germany)
• RTI Surgical Holdings Inc. (U.S.)
• Osseon Therapeutics Inc. (U.S.)
• Spine Wave Inc. (U.S.)
• Benvenue Medical Inc. (U.S.)
• CareFusion (BD) (U.S.)
• Richard Wolf GmbH (Germany)
• B. Braun Melsungen AG (Germany)
• Medacta International (Switzerland)
• Globus Spine (U.S.)
• Alphatec Spine (U.S.)
• Beijing Wad Medical Co., Ltd. (China)
• Lepu Medical Technology (China)
• Shandong Weigao Group Medical Polymer (China)
• Shanghai Kinetic Medical Co., Ltd. (China)
• SGM Medical (South Korea)
• Wuxi Betta Pharmaceutical (China)
• Auxein Medical (India)
• Siora Surgicals Pvt. Ltd. (India)
• Meril Life Sciences (India)

Latest Developments in Vertebroplasty and Kyphoplasty Market

• In September 2024, XeliteMed received FDA clearance for its VertehighFix high-viscosity spinal bone cement system used in vertebroplasty and kyphoplasty procedures. The product is indicated for stabilizing pathological vertebral fractures caused by osteoporosis and tumors. This development reflects ongoing innovation in bone cement formulations aimed at reducing leakage risk and improving procedural safety in vertebral augmentation procedures.
• In June 2024, Medtronic announced a strategic expansion of its Kyphon portfolio through collaboration with Merit Medical Systems to enhance balloon kyphoplasty delivery systems. The partnership aimed to improve minimally invasive treatment options for vertebral compression fractures by integrating advanced unipedicular balloon catheter technology. This development strengthened Medtronic’s leadership in vertebral augmentation by improving procedural efficiency and expanding device accessibility.
• In May 2025, Stryker received FDA clearance for its OptaBlate BVN system, expanding its interventional spine portfolio beyond kyphoplasty into basivertebral nerve ablation. Although primarily targeting vertebrogenic back pain, this development strengthens Stryker’s broader spinal intervention ecosystem, indirectly supporting demand for vertebral augmentation procedures by expanding minimally invasive treatment pathways.
• In September 2025, Amber Implants received FDA 510(k) clearance for its VCFix vertebral augmentation system for the treatment of vertebral compression fractures. The system is designed to improve spinal stabilization using minimally invasive techniques and bone cement-based support. Clinical trial results showed significant improvements in pain reduction and recovery outcomes, positioning it as a next-generation vertebral augmentation technology.
• In March 2026 (late-stage development based on 2025 clearance), Medtronic and Merit Medical expanded distribution agreements for FDA-cleared basivertebral nerve ablation systems linked to vertebral fracture management. This reflects increasing integration of interventional pain therapies with vertebral augmentation ecosystems, expanding treatment pathways for chronic vertebrogenic pain and post-fracture management

SKU-55919